Amgen Drops Eczema Drug Pact As Investors Weigh R&D Focus And Valuation simplywall.st Source link
Amgen Lawsuit And Eczema Drug Exit Reframe Risk And R&D Priorities simplywall.st Source link
Sanofi to seek approval of touted eczema drug despite mixed results biopharmadive.com Source link
Dermatology Drug News in Review: Key FDA Updates From 2025 Dermatology Advisor Source link